Torrent Pharma’s acquisition of JB Chemicals & Pharmaceuticals propels it to become India’s fifth-largest pharmaceutical company, capturing a 4.6% market share. This deal significantly strengthens Torrent’s position in the cardiac therapy market, overtaking Sun Pharma with nearly 11% share. The acquisition boosts Torrent’s presence in key therapeutic areas, with consolidated revenues exceeding Rs 15,000 crore.